Switch theme
Sign up to access all valuation multiples
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
2021
2.6K+
LTM Revenue $1.1B
LTM EBITDA $195M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr. Martens has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of $195M.
In the most recent fiscal year, Dr. Martens achieved revenue of $1.2B and an EBITDA of $264M.
Dr. Martens expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr. Martens valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Profit | $709M | XXX | $772M | XXX | XXX | XXX |
| Gross Margin | 66% | XXX | 66% | XXX | XXX | XXX |
| EBITDA | $195M | XXX | $264M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $88.1M | XXX | $170M | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $34.4M | XXX | $92.9M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $235M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Dr. Martens's stock price is GBP 1 (or $1).
Dr. Martens has current market cap of GBP 557M (or $748M), and EV of GBP 912M (or $1.2B).
See Dr. Martens trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $748M | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Dr. Martens has market cap of $748M and EV of $1.2B.
Dr. Martens's trades at 1.1x EV/Revenue multiple, and 6.0x EV/EBITDA.
Equity research analysts estimate Dr. Martens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr. Martens has a P/E ratio of 21.7x.
See valuation multiples for Dr. Martens and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $748M | XXX | $748M | XXX | XXX | XXX |
| EV (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 6.3x | XXX | 6.0x | XXX | XXX | XXX |
| EV/EBIT | 13.9x | XXX | 11.8x | XXX | XXX | XXX |
| EV/Gross Profit | 1.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.7x | XXX | 16.7x | XXX | XXX | XXX |
| EV/FCF | 15.1x | XXX | 11.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDr. Martens's last 12 month revenue growth is 6%
Dr. Martens's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Dr. Martens's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr. Martens's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dr. Martens and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | -10% | XXX | XXX | XXX |
| Rule of 40 | 28% | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 51% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brillia Inc | XXX | XXX | XXX | XXX | XXX | XXX |
| Cettire | XXX | XXX | XXX | XXX | XXX | XXX |
| Merino | XXX | XXX | XXX | XXX | XXX | XXX |
| Premier Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Step One Clothing | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Martens acquired XXX companies to date.
Last acquisition by Dr. Martens was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr. Martens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Dr. Martens founded? | Dr. Martens was founded in 2021. |
| Where is Dr. Martens headquartered? | Dr. Martens is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Dr. Martens have? | As of today, Dr. Martens has 2.6K+ employees. |
| Who is the CEO of Dr. Martens? | Dr. Martens's CEO is Mr. Ije Nwokorie. |
| Is Dr. Martens publicy listed? | Yes, Dr. Martens is a public company listed on LON. |
| What is the stock symbol of Dr. Martens? | Dr. Martens trades under DOCS ticker. |
| When did Dr. Martens go public? | Dr. Martens went public in 2021. |
| Who are competitors of Dr. Martens? | Similar companies to Dr. Martens include e.g. Brillia Inc, Cettire, Merino, Premier Investments. |
| What is the current market cap of Dr. Martens? | Dr. Martens's current market cap is $748M |
| What is the current revenue of Dr. Martens? | Dr. Martens's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Dr. Martens? | Dr. Martens revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Dr. Martens? | Current revenue multiple of Dr. Martens is 1.1x. |
| Is Dr. Martens profitable? | Yes, Dr. Martens is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dr. Martens? | Dr. Martens's last 12 months EBITDA is $195M. |
| What is Dr. Martens's EBITDA margin? | Dr. Martens's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Dr. Martens? | Current EBITDA multiple of Dr. Martens is 6.3x. |
| What is the current FCF of Dr. Martens? | Dr. Martens's last 12 months FCF is $80.9M. |
| What is Dr. Martens's FCF margin? | Dr. Martens's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Dr. Martens? | Current FCF multiple of Dr. Martens is 15.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
